Renaissance Capital Partners Ltd - 30 Nov 2022 Form 4 Insider Report for TC BioPharm (Holdings) plc (TCBPY)

Role
10%+ Owner
Signature
/s/ Thomas Nicholls
Issuer symbol
TCBPY
Transactions as of
30 Nov 2022
Net transactions value
+$350,000
Form type
4
Filing time
11 Jan 2023, 13:17:26 UTC
Previous filing
27 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCBP Ordinary Shares [ADS] Purchase $350,000 +70,000 +105% $5.00* 136,834 30 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCBP Series A Warrants Purchase $0 +70,000 $0.000000 70,000 30 Nov 2022 Ordinary Shares 70,000 $5.00 Direct F1
transaction TCBP Series B Warrants Purchase $0 +70,000 $0.000000 70,000 30 Nov 2022 Ordinary Shares 70,000 $5.00 Direct F2
holding TCBP Warrants 106,129 30 Nov 2022 Ordinary Shares 106,129 $4.25 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Series A Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.
F2 Series B Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.